Where is CytomX headquartered?

CytomX is located in South San Francisco, CA.

Who invested in CytomX?

CytomX has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for CytomX?

CytomX closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

cytomx.com

CytomX

CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases.

Business Model:

Revenue: $71.9M

Employees: 51-200

Geographic Data

Address: 151 Oyster Point Boulevard

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$94M

Raised Total:

$291M

Social

Twitter

Crunchbase

Metrics

77,564Website Global Rank

1,622,290Website Monthly Traffic

Twitter Followers

Description

CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases.

Contact Phone:
+16505153185

Contact Email:

IPO Details

CytomX went public on 10/8/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/8/2015

Ticker Symbol:
CTMX

IPO Price:
$12/share

Amount Raised:
$80M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2015	Series C	4	$20M	Canaan Partners Third Rock Ventures Pfizer Venture Investments Roche Venture Fund Canaan Partners Third Rock Ventures Pfizer Venture Investments
6/2015	Series D	8	$70M	Wellington Management Cormorant Asset Management Deepfield Casdin Capital Tekla Capital Management Perceptive Advisors Venrock Redmile Group Wellington Management Cormorant Asset Management Deepfield Casdin Capital Tekla Capital Management Perceptive Advisors Venrock Redmile Group
7/2012	Series B	2	$11M	Canaan Partners Third Rock Ventures Canaan Partners Third Rock Ventures
4/2014	Series B		$1.4M
7/2018	Post-IPO Equity		$116.9M
3/2010	Convertible Note	1	$2.5M	Mike Panesis
2/2015	Series C		$1.5M
1/2021	Post-IPO Equity		$93.6M
10/2015	IPO		$80M
9/2010	Series B	2	$30M	Third Rock Ventures Roche Venture Fund Third Rock Ventures
6/2015	Series D		$70M	Deerfield Management Casdin Capital Redmile Group Tekla Healthcare Investors venrock healthcare capital partners Wellington Management Co
12/2014	Series C		$16.5M	Third Rock Ventures Canaan Partners

Acquisitions

Announced Date	Name	Price
3/2005	Ardais Corporation

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details